Skip to main content
Equibles

Matt Vellatore

Analyst

Goldman Sachs

Equibles does not estimate personal net worth.

About Matt Vellatore

Matt Vellatore is recorded as Analyst at Goldman Sachs. Matt Vellatore has spoken on 1 earnings call across 1 company, most recently for Amneal Pharmaceuticals, Inc. on February 27, 2026. The companies whose calls Matt Vellatore spoke on are classified in the Healthcare sector.

Matt Vellatore on recent calls

“Maybe on the Pfizer-Glip1 obesity partnership, could you just share your latest update on the status of that partnership, and then how should we think about potential outcomes?”
Analyst — Goldman Sachs, Amneal Pharmaceuticals, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • Goldman Sachs

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity